Signaling pathways
-
BA2688 MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-ExatecanSummary: MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan is part of an antibody-coupled active molecule consisting of (MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic) coupled to a DNA topoisomerase I inhibitor. - BA2690 DBCO-PEG4-MMAFSummary: DBCO-PEG4-MMAF is part of an antibody-coupled active molecule consisting of MMAF, an inhibitor of microtubule protein polymerization, and degradable DBCO-PEG4.
- BA2691 Mc-Alanyl-Alanyl-Asparagine-PAB-MMAESummary: Mc-Alanyl-Asparagine-PAB-MMAE is a potent anticancer agent (agent) that is specifically activated by the tumor microenvironment.
- BA2692 Val-Cit-PAB-ExatecanSummary: Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) is part of an antibody-activator coupling.
- BA2693 AcLys-PABC-VC-Aur0101Summary: AcLys-PABC-VC-Aur0101 is part of an antibody-coupled active molecule (anti-ADC).
- BA2694 Fmoc-Val-Cit-PAB-MMAESummary: Fmoc-Val-Cit-PAB-MMAE consists of (Fmoc-Val-Cit-PAB) and MMAE, a potent microtubule (tubulin) inhibitor.
- BA2695 MP-PEG4-Val-Lys-Gly-7-MAD-MDCPTSummary: MP-PEG4-Val-Lys-Gly-7-MAD-MDCPT.
- BA2696 PSMA-ALB-56Summary: PSMA-ALB-56 is a PSMA-targeting radioligand.
- BA2697 IM-2Summary: IM-2 is a linker.
- BA2698 DBCO-PEG4-Ahx-DM1Summary: DBCO-PEG4-Ahx-DM1 is an active molecule binding agent consisting of the microtubule protein inhibitor DM1 and the linker DBCO-PEG4-Ahx.